Immucell Corp (ICCC) Reports Q2 EPS of $0.00
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
ImmuCell Announces Second Quarter 2016 Financial Results
August 11, 2016 4:05 PM EDTPORTLAND, ME -- (Marketwired) -- 08/11/16 -- ImmuCell Corporation (NASDAQ: ICCC), a growing animal health company that is developing, manufacturing and selling products that improve health and productivity in the dairy and beef industries, today announced financial results for its second quarter ended June 30, 2016.
2016 Second Quarter Financial Overview:
Total sales of $2.4 million increased by 21%, or $415,000, during the second quarter of 2016 compared to the second quarter of 2015;Total sales of $5.4 million increased by 6%, or $300,000, during the six-month period ended June 30, 2016... More